AccuStem Sciences sells 1.34M shares to Tiziana Life Sciences at $2.00/sh, raising $2.68M; CEO also joins board

Accustem Sciences Inc.

Tiziana Life Sciences purchased 1,337,970 shares of AccuStem common stock at $2.00 per share for gross proceeds of $2,675,940.
Sale was pursuant to a Supplemental Demerger Agreement from Oct 2021, requiring Tiziana to buy £2M shares at listing.
Shares are unregistered and offered under Regulation S exemption.
CEO Wendy Blosser appointed to the Board of Directors, effective March 30, 2022.

item 1.01 item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Wendy Blosser

director

ACUT · Accustem Sciences Inc.

Effective: 2022-03-30
Filed: April 5, 2022, 7:59 PM ET

On March 30, 2022, the Board of Directors of the Company appointed Wendy Blosser, the Company’s Chief Executive Officer as a director to serve on the Board and to hold office until the next annual meeting of stockholders and until her successor is duly elected and qualified

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Wendy Blosser was appointed as director at Accustem Sciences Inc..

Action: appointed
Role: director

Exact text from the filing

On March 30, 2022, the Board of Directors of the Company appointed Wendy Blosser, the Company’s Chief Executive Officer as a director to serve on the Board and to hold office until the next annual meeting of stockholders and until her successor is duly elected and qualified

View on SEC.gov

Accustem Sciences Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-009142

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.